🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00808Y307 (prev. 00808Y109 )
- Market Cap
- Micro Cap
- Previous Symbol
- BSEQ (changed 3/10/2000)
- Previous Name
- Bishop Equities, Inc.
Business: Aethlon Medical, Inc. is a United States based, developmental-stage company. The Company is engaged in creating medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Aethlon's ADAPT System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system.
Notes: Oct. 14, 2019 -- Aethlon Medical, Inc. (Nasdaq: AEMD) ("Aethlon" or the "Company"), a therapeutic medical device and technology company focused on unmet needs in global health, announced today that at the annual meeting of stockholders of the Company, held October 14, 2019, its stockholders voted to approve a proposal authorizing the Board of Directors of the Company to effect a reverse stock split of Aethlon's outstanding common stock. Following the special meeting of stockholders, the Board of Directors approved a 1-for-15 reverse stock split. The common shares will trade under a new CUSIP number, 00808Y307, effective October 15, 2019.
Company Contact
- CEO
- Charles J. Fisher, Jr
- CFO
- James B. Frakes
- Headquarters
- 11555 Sorrento Valley Road, Suite 203, San Diego, CA 92121
- Phone
- 619-941-0360
- Fax
- 858-467-0800
- Investor Relations
- Susan Noonan, S.A. Noonan Communications · susan@sanoonan.com